Cutaneous aspergillosis.
van Burik JA, Colven R, Spach DH.
J Clin Microbiol. 1998 Nov;36(11):3115-21. doi: 10.1128/JCM.36.11.3115-3121.1998.
Cutaneous aspergillosis.
Isaac M.
Dermatol Clin. 1996 Jan;14(1):137-40. doi: 10.1016/s0733-8635(05)70333-8.
Cutaneous aspergillosis.
Böhler K, Metze D, Poitschek C, Jurecka W.
Clin Exp Dermatol. 1990 Nov;15(6):446-50. doi: 10.1111/j.1365-2230.1990.tb02141.x.
Primary Cutaneous Aspergillosis Caused by Aspergillus ochraceus.
Yang X, Yang X.
Mycopathologia. 2023 Oct;188(5):829-831. doi: 10.1007/s11046-023-00774-6. Epub 2023 Jul 21.
Cutaneous aspergillosis disseminated from invasive pulmonary aspergillosis.
Sato S, Tamai Y.
Int J Infect Dis. 2019 Oct;87:13-14. doi: 10.1016/j.ijid.2019.08.005. Epub 2019 Aug 8.
Dupilumab: A Review of Present Indications and Off-Label Uses.
Muñoz-Bellido FJ, Moreno E, Dávila I.
J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):97-115. doi: 10.18176/jiaci.0682. Epub 2021 Mar 3.
Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review.
Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, Lortholary O, Chosidow O, Bretagne S; French Mycosis Study Group.
Medicine (Baltimore). 2015 Jul;94(26):e1018. doi: 10.1097/MD.0000000000001018.
Primary Cutaneous Aspergillosis in a Patient with CARD9 Deficiency and Aspergillus Susceptibility of Card9 Knockout Mice.
Zhang Y, Huang C, Song Y, Ma Y, Wan Z, Zhu X, Wang X, Li R.
J Clin Immunol. 2021 Feb;41(2):427-440. doi: 10.1007/s10875-020-00909-0. Epub 2020 Nov 12.
Cutaneous mucormycosis.
Vulsteke JB, Deeren D.
Transpl Infect Dis. 2019 Apr;21(2):e13039. doi: 10.1111/tid.13039. Epub 2019 Jan 4.
Cutaneous aspergillosis masquerading in sporotrichoid morphology in an immunocompetent host.
Pathania V, Sandhu S, Sengupta P, Kaur K.
Med J Armed Forces India. 2022 Apr;78(2):235-238. doi: 10.1016/j.mjafi.2020.10.020. Epub 2020 Dec 31.
